David Millan

Chief Scientific Officer, Auron Therapeutics

Role
Chief Scientific Officer at Auron Therapeutics, Inc
Location
Newton, MA, US
LinkedIn followers
500 followers

About David Millan

An accomplished and entrepreneurial drug discovery leader with 25 years of scientific and operational leadership experience spanning privately funded Biotech start-ups through to mid- and large cap Pharma. Therapeutic area experience includes oncology/ IO, respiratory, metabolic diseases, inflammation, & neuro/ pain. Played key roles in the discovery of 10+ first-in-class development candidates, with several progressing to Phase 2 clinical development. Expertise developed in a diversity of target classes, drugging modalities and technologies, through all stages of the drug discovery continuum. A confident leader and communicator that can develop and articulate vision. Significant experience of building, developing and motivating teams to achieve challenging goals. Driven by a deep curiosity and passion for the intersection of human disease, new therapy development and value creation.

Experience

  1. Chief Scientific Officer

    Auron Therapeutics, Inc

    Dec 2021 — Present · Newton, MA, US

    Auron Therapeutics is a platform-powered, product-driven company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease. Auron pioneered its AURIGIN™ platform, which uses AI and machine learning to compare cell states and identify novel drug targets, optimal development models, and biomarkers to facilitate proper patient selection, ultimately accelerating the development of effective and durable therapies. Using AURIGIN, the Company is building a pipeline of small molecule targeted therapies, led by a first-in-class, oral KAT2A/B degrader, AUTX-703, which is being developed for the treatment of both hematologic malignancies and solid tumors.

Education

  • Flinders University

    Bachelor of Science (Hons), Chemistry with Molecular Biology and Biochemistry

    1992 — 1995

  • Flinders University

    PhD, Synthetic Organic Chemistry

    1996 — 1999

Skills

  • Leading Meetings
  • Project Management
  • Pharmacokinetics
  • Drug Delivery
  • Lead Change
  • Drug Discovery
  • Organic Synthesis
  • Lead Optimisation
  • Clinical Trials
  • Organic Chemistry
  • Leadership
  • Adme
  • Biotechnology
  • Mentoring
  • Communication
  • In Vitro Toxicology
  • Drug Metabolism
  • Drug Design
  • Chemistry
  • Life Sciences
  • Pharmaceutical Industry
  • Drug Safety
  • Lead Generation
  • Cancer Research
  • Protein Kinases
  • Written & Oral Presentation Skills
  • Medicinal Chemistry
  • Science
  • Respiratory Therapy
  • Pharmaceutical Sciences
  • Synthetic Organic Chemistry
  • Team Leadership
  • Dmpk

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

David Millan — Chief Scientific Officer at Auron Therapeutics, Inc in Newton, MA, US | Unifers